Organizations
Conferences
Info & Opinion
Pfizer’s quarterly earnings fell sharply, with net income dropping 77 percent. The company’s R&D budget shank by five percent as part of a previously announced cost-cutting effort. Lipitor sales were also down by 5 percent. The financial picture was marred…
No articles available